CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79 | -26.9% | 97,000 | +1.6% | 0.00% | – |
| Q2 2023 | $108 | +21.3% | 95,500 | +7.2% | 0.00% | – |
| Q1 2023 | $89 | +21.9% | 89,100 | +6.2% | 0.00% | – |
| Q4 2022 | $73 | -99.9% | 83,900 | +0.7% | 0.00% | – |
| Q3 2022 | $107,000 | +84.5% | 83,300 | +24.5% | 0.00% | – |
| Q2 2022 | $58,000 | -18.3% | 66,900 | +184.7% | 0.00% | – |
| Q1 2022 | $71,000 | +26.8% | 23,500 | +117.6% | 0.00% | – |
| Q4 2021 | $56,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,991,003 | $5,725,631 | 0.11% |
| Kynam Capital Management, LP | 535,005 | $434,003 | 0.07% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 603,900 | $468,626 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 650,000 | $532,350 | 0.00% |
| Qube Research & Technologies Ltd | 46 | $36 | 0.00% |
| JPMORGAN CHASE & CO | 23,532 | $18,249 | 0.00% |
| Renaissance Technologies | 97,000 | $79 | 0.00% |
| ROYAL BANK OF CANADA | 255 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 16,520 | $12,802 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 17,219 | $14,102 | 0.00% |